运行x2
间充质干细胞
间质细胞
骨形态发生蛋白2
碱性磷酸酶
细胞生物学
细胞分化
小RNA
化学
荧光素酶
生物
细胞培养
癌症研究
生物化学
体外
转染
遗传学
酶
基因
作者
Qiting He,Ruibin Li,Beibei Hu,Xuezhou Li,Yunpeng Wu,Pengfei Sun,Yuhua Jia,Yongyuan Guo
摘要
Abstract Background Stromal cell‐derived factor‐1 (SDF‐1) plays an important role in the osteoblastic differentiation of human bone marrow mesenchymal stem cells (hBMMSCs), but the specific mechanism remains unclear. Our study aimed to clarify the role of the lncRNA‐H19/miR‐214‐5p/BMP2 axis in the osteoblastic differentiation of hBMMSCs induced by SDF‐1. Methods We used reverse‐transcriptase polymerase chain reaction, western blotting, alkaline phosphatase activity test, and Alizarin red staining to evaluate the osteoblastic differentiation of primary hBMMSCs and the luciferase reporter assay to determine if lncRNA‐H19 binds with miR‐214‐5p. Results Our results indicated that SDF‐1 (50 ng/mL) promotes the osteoblastic differentiation of hBMMSCs, significantly upregulates osteoblastogenic genes ( OCN , OSX , RUNX2 , and ALP ), and increases Alizarin red staining, alkaline phosphatase activity, and lncRNA‐H19 expression. Luciferase reporter assay verified that lncRNA‐H19 binds with and represses miR‐214‐5p, thereby upregulating BMP2 expression. Use of miR‐214‐5p inhibitor or overexpression of lncRNA‐H19 can promote the osteoblastic differentiation of hBMMSCs, but miR‐214‐5p or shH19 inhibits the osteoblastic differentiation of hBMMSCs. Treatment with an miR‐214‐5p inhibitor could rescue the inhibitory effect of shH19 on the osteoblastic differentiation of hBMMSCs. Conclusions Taken together, SDF‐1 promotes the osteoblastic differentiation of hBMMSCs through the lncRNA‐H19/miR‐214‐5p/BMP2 axis. Increased osteoblastic differentiation by an miR‐214‐5p inhibitor reveals a new possible strategy for the treatment of bone defect and osteoporosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI